Riskpilot← Back to searchSign inGet full accessBiolegal AB
ABActiveOrg 5591191175Övre Slottsgatan 28 ALegal activities · NACE 6910Est. 20171 employees
Revenue 2024
SEK 2,1M
-48% vs 2023
EBITDA margin
37.4%
-72% vs 2023
Equity ratio
23.4%
Financial strength
Net profit 2024
SEK 515K
-70% vs 2023
| Revenue | SEK 2,1M | -48% |
| EBITDA | SEK 793K | -72% |
| Net profit | SEK 515K | -70% |
| Total assets | SEK 2,5M | -44% |
| Equity | SEK 597K | -68% |
| Employees | 1 | — |
Legal name
Biolegal AB
Org number
5591191175
Legal form
Aktiebolag
NACE code
6910 · Legal activities
Founded
12 juli 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva juridisk och ekonomisk rådgivnings- och konsultverksamhet, system-, produkt- , och affärsutveckling för drivande av webbaserade tjänster för information och försäljning av produkter och tjänster företrädesvis inom juridik och ekonomi, förvärva och förvalta lös och fast egendom, samt bedriva annan därmed förenlig verksamhet.
Address
Övre Slottsgatan 28 A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 3 822 | 4 115 | 2 122 |
| Staff expenses | — | — | −674 | −971 | −1 013 |
| EBITDA | −2 | −1 | 2 746 | 2 848 | 793 |
| Depreciation & amort. | −0 | −0 | — | −2 | −12 |
| EBIT | −2 | −1 | 2 746 | 2 846 | 781 |
| Net financials | — | — | 0 | 37 | 32 |
| Profit before tax | −2 | −1 | 2 055 | 2 158 | 663 |
| Tax | −0 | −0 | −427 | −448 | −148 |
| Net profit | −2 | −1 | 1 628 | 1 710 | 515 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 45 | 43 | 3 230 | 4 529 | 2 545 |
| Equity | 45 | 43 | 1 671 | 1 881 | 597 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 0 | 0 | 868 | 1 232 | 382 |
| Total debt | — | — | 868 | 1 232 | 382 |
EBITDA margin
37.4%
This company
15.8%
Market median
+137% vs market
20202024
Equity ratio
23.4%
This company
38.2%
Market median
-39% vs market
20202024
Return on equity
86.4%
This company
18.4%
Market median
+370% vs market
20202024
Net profit margin
24.3%
This company
8.1%
Market median
+200% vs market
20202024
Asset turnover
0.83×
This company
1.12×
Market median
+26% vs market
20202024
Debt / equity
3.26×
This company
0.62×
Market median
-426% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SF Audit | Audit | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Legal Forward AB
Biolegal AB Board members of Biolegal AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stefan Folke Adebahr | Audit | 0 companies |
| Åsa Christine Gibson | Deputy Board Member | 0 companies |
| Freed Jonas Gibson | Board of Directors | 0 companies |